Cell Biosciences Completes Acquisition of Alpha Innotech

Cell Biosciences, Inc. (Santa Clara, CA, USA) has completed its acquisition of Alpha Innotech Corp. (San Leandro, CA, USA). Pursuant to the merger agreement announced on September 8, 2009, former Alpha Innotech stockholders will receive US$1.50 per share or approximately $17.9 million in cash and will assume $2.1 million of outstanding debt, net of cash. The acquisition will significantly expand Cell Biosciences' protein analysis business to include a global infrastructure and a broad protein analysis product portfolio.

A private life sciences company, Cell Biosciences is focused on nanoproteomics. The company's lead product is the CB1000, a nanofluidic immunoassay platform designed for ultrasensitive detection and characterization of oncoproteins and other signaling proteins in ultra-small biological samples, such as small tumor biopsies and stem cells.

Cell Biosciences develops instrumentation systems, software, and assay products that reveal previously undetectable information about cellular control pathways. The company's products enable scientists to uncover fundamental mechanisms controlling cell proliferation and cell death, to accelerate the development of new therapeutics, and to help identify new prognostic and diagnostic disease biomarkers.

Alpha Innotech is a pioneer in the use of high-sensitivity digital imaging systems for genomic and proteomic research. The company offers a broad range of products, from entry-level gel documentation systems to premier systems for multiplexed fluorescence and proteomics applications. The company has sold over 10,000 systems worldwide.

Tim Harkness, president and CEO of Cell Biosciences, commented, "This strategic acquisition marks an important milestone in our plan to create a profitable, high-growth protein analysis business with global reach. There is a great strategic fit in people, products, technologies, and customers between Cell Biosciences and Alpha Innotech. I am particularly excited by the critical mass of talent and industry experience this combination creates."

Related Links:
Cell Biosciences, Inc.
Alpha Innotech Corp.